Related Experiment Video
Updated: Mar 26, 2026

Author Spotlight: Innovative Methods in Lymphedema and Hypertension Research
Published on: March 22, 2024
[Nicardipine-induced gingival hyperplasia]
I Pascual-Castroviejo1, S I Pascual Pascual
1Servicio de Neurología Pediátrica, Hospital Infantil La Paz, Madrid.
Abstract:
Drug-induced gingival hyperplasia is usually associated with the administration of hydantoin in individuals with epilepsy. The same side effect has also been reported, however, after administration of cyclosporin and some calcium channel blockers such as nifedipine, verapamil, diltiazem and nitrendipine in adults generally or in the elderly, as well as after experimental exodipin administration to rats. We report an 8.5-years-old boy who had been receiving nicardipine treatment for cerebral vascular disease since the age of 20 months, with gradually increasing doses and no side effects for 5 years. Gingival hyperplasia then presented and progressed over the next two years after the dose was increased from 40 to 50 mg/day. The patient was not taking and has never taken any other medication. This is the first case of gingival hyperplasia induced by nicardipine described to date.
More Related Videos
08:03Hybrid Cell Analysis System to Assess Structural and Contractile Changes of Human iPSC-Derived Cardiomyocytes for Preclinical Cardiac Risk Evaluation
Published on: October 20, 2022
06:53A Rat Carotid Artery Pressure-Controlled Segmental Balloon Injury with Periadventitial Therapeutic Application
Published on: July 9, 2020
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease II: Pathophysiology
Cardiac Catheterization I: Pre-Procedure Overview
Antianginal Drugs: Calcium Channel Blockers and Ranolazine
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Antihypertensive Drugs: Vasodilators